do-me/EUR-LEX huggingface dataset:
WRITTEN QUESTION No. 2282/96 by Joan COLOM I NAVAL to the Commission. Quality of bathing water in Germany
Date: 1996-08-27
Institutions: COLOM I NAVAL, European Parliament
Subjects: Germany, application of EU law, bathing water, infringement procedure (EU), inland waters, quality of the environment, territorial waters, water pollution













EUR-Lex - 91996E2282 - EN






Avis juridique important




|



91996E2282

WRITTEN QUESTION No. 2282/96 by Joan COLOM I NAVAL to the Commission. Quality of bathing water in Germany  


Official Journal C 011 , 13/01/1997 P. 0076 





WRITTEN QUESTION E-2282/96 by Joan Colom i Naval (PSE) to the Commission (27 August 1996)Subject: Quality of bathing water in GermanyAccording to the Commission's thirteenth report on the quality of bathing water in 1995, only 46% of the inland waters met the necessary quality standards.Has the Commission taken any steps to remedy this situation?Joint answer to Written Questions E-2281/96 and E-2282/96 given by Mrs Bjerregaard on behalf of the Commission (25 September 1996)The unsatisfactory quality of bathing water in the Netherlands was indicated in the recently published Commission report on the quality of bathing water in 1995.The Commission has decided to question the Dutch authorities on this matter through a letter of formal notice - the first step in the procedure laid down in Article 169 of the EC Treaty.Regarding the poor quality of inland bathing waters in Germany, the Commission, having identified the situation some time ago, has instituted infringement proceedings. A reasoned opinion, the last step in the Article 169 procedure before the matter goes before the Court, has already been notified. Proceedings are continuing.
WRITTEN QUESTION No. 2313/96 by Maartje van PUTTEN to the Commission. Contraceptive 'mini-pill' - access to information
Date: 1996-08-27
Institutions: European Parliament, VAN PUTTEN
Subjects: access to information, cardiovascular disease, contraception, medical research, medicinal product, public health













EUR-Lex - 91996E2313 - EN






Avis juridique important




|



91996E2313

WRITTEN QUESTION No. 2313/96 by Maartje van PUTTEN to the Commission. Contraceptive 'mini-pill' - access to information  


Official Journal C 072 , 07/03/1997 P. 0028 





WRITTEN QUESTION E-2313/96 by Maartje van Putten (PSE) to the Commission (27 August 1996)Subject: Contraceptive 'mini-pill' - access to informationIn its answer to written question P-3141/95 ((OJ C 66, 4.3.1996, p. 62. )) by Mrs Hiltrud Breyer, the Commission refers to three unpublished studies which were brought to the attention of the committee for proprietary medicinal products (CPMP) at its meeting of 17 to 19 October 1995. The studies apparently suggest that there is an increased risk (although still low) of venous thrombo-embolism with third generation oral contraceptives. The studies included a multinational study carried out for the WHO.1. Is the Commission aware that information on the form of this WHO study and the data which it uses is not available to the public?2. Does the Commission not agree that producers and consumers of the products examined in the study have a right to access to this information?3. Is the Commission prepared to make an active contribution towards making this information available. If so, what action does it intend to take?Answer given by Mr Bangemann on behalf of the Commission (10 October 1996)The Honourable Member asks about the studies which formed the basis of the considerations of the committee for proprietary medicinal products (October 1995) in relation to the safety of combined oral contraceptives containing desogestrol and gestodene.The studies which were identified have since been published and are therefore generally available as follows:- a multinational study carried out for the World health organisation (WHO) published (in two parts) in Lancet 16.10.95, ref. WHO collaborating group, Lancet 1995, 346: 1582-1588 and 346: 1575-1982.- a cohort study based on record linkage carried out by Professor H.Jick,published in Lancet 16.10.95, ref.Jick et al, Lancet 1995, 346: 1589-1593;- a transnational study carried out by Professor W.O. Spitzer, published in British medical journal, 13.1.96, ref. Spitzer et al, British Medical Journal, 312: 83-90.